A study led by UC San Diego sheds light on why Alzheimer’s drugs so far have been ineffective at curing or reversing the disease. The researchers identify new targets for drug development and present a new method to screen drugs for treating Alzheimer’s disease.
Related Articles

News
With a $50 Million Gift, USC and UC San Diego Join Forces in Alzheimer’s Research
January 24, 2022
sandiegobiotech
News, UCSD News
Comments Off on With a $50 Million Gift, USC and UC San Diego Join Forces in Alzheimer’s Research
A joint gift to the University of Southern California (USC) and the University of California San Diego totaling $50 million from the Epstein Family Foundation will drive Alzheimer’s research and accelerate the s… […]

News
Frank Würthwein Named Director of the San Diego Supercomputer Center
November 30, 2021
sandiegobiotech
News, UCSD News
Comments Off on Frank Würthwein Named Director of the San Diego Supercomputer Center
The San Diego Supercomputer Center has a new director. Frank Würthwein, lead of SDSC’s Distributed High-Throughput Computing Group, executive director of the Open Science Grid, a physics professor and a founding… […]

News
Step Up: Walking May Reduce Type 2 Diabetes Risk for Adults 65 and Older
January 20, 2022
sandiegobiotech
News, UCSD News
Comments Off on Step Up: Walking May Reduce Type 2 Diabetes Risk for Adults 65 and Older
UC San Diego Herbert Wertheim School of Public Health study reports that the more steps taken, and the more intense, the lower the risk of Type 2 diabetes among women 65 and older.
[…]